COMPARATIVE EVALUATION OF COMBINATION THERAPY OF IMIPENAM– CILASTATIN VERSUS CEFTAZIDIME–AMIKACIN IN PATIENTS WITH FEBRILE NEUTROPENIA - Current Issue - IJSR